syngo.via, the intelligent multi-modality imaging software, enhances your daily routine: it provides powerful tools for an easier and more productive diagnostic workflow. Latest technologies like AI take reading and reporting to the next level and help to advance your clinical decision-making.
With new and improved applications, syngo.via1 enables a 360° view for image-based treatment decisions in oncology.
New applications
syngo.MR OncoCare offers a solution for quantitative evaluation of functional tumor response to treatment. It has the potential to allow earlier assessment of treatment response, leading to treatment path optimization and savings of unnecessary treatment costs.
Discover syngo.MR OncoCare
In radiotherapy tools are lacking that are designed for multimodality image viewing and contouring. syngo.via RT Image Suite closes this gap. It allows you to leverage your image data to get a clear and comprehensive view of your patient and also increases efficiency with an easy-to-use contouring solution designed for radiation oncologists.
Communicating and sharing the visual and quantitative evidence of oncological diseases can be challenging to do offline. With syngo.MI Offline Oncoboard being designed to easily share oncological findings in settings such as tumor boards to support sound, multi-disciplinary treatment decisions. Using external storage media like USB for example enables you to quickly start to review a case and share findings on virtually any PC.
Thanks to the new consolidated MR oncology workflow you can now find all functionalities embedded into one workflow. For efficient evaluation of multiple tumor types or lesions, the Easy Reading Mode allows to quickly read through the acquired series.
Color-coded follow-up VRTs help you avoid time-consuming manual lesion comparison across multiple time-points. The color coding simplifies assessments of tumor volume and trending visible.
Vendor-neutral Link-it enables you to efficiently compare mammography images from Siemens systems and other vendors. No matter whether you are looking at 2D, 3D, prior, follow-up, or current images, the automated ROI location will help you achieve best outcomes.
syngo.via1 supports treatment decisions in oncology – from diagnosis to follow-up. Discover further application highlights from syngo.via’s oncology portfolio.
Highlights that support treatment decisions
syngo.CT Body Perfusion facilitates the detailed quantitative evaluation of perfusion disturbances and changes in organs and tumors during therapy. This is particularly helpful in the differential diagnosis and monitoring of tumors.
syngo.CT Liver Analysis provides you with preprocessed segmentation results. It offers intuitive workflow guidance for in-depth analysis of vascular supply areas of the liver, allowing a clear comparison of resected and residual liver volume.
syngo.mMR General is designed for the professional visualization and quantitative analysis of MR-PET examinations. The application loads and structures examination results into meaningful layouts. It supports you with lesion detection, staging, and follow-up across multiple time points.
syngo.PET Segmentation with EQ.PET enables the comparison of longitudinal patient exams for determination of disease manifestation and change – independent of scanner vendor, model, or reconstruction algorithms.
syngo.PET&CT Therapy interface helps convert diagnostic PET and CT segmentations into Gross Tumor Volumes (GTV) and publishes them as DICOM RT Structure Sets for use in radiotherapy treatment planning. This helps simplify interdisciplinary collaboration.
syngo.via WebViewer3 enables fast and easy image access in time-critical situations or when on-call. It provides access to high-quality images for physicians outside Radiology. syngo.via WebViewer is also suitable for discussing results with patients.
syngo.via can be used as a standalone device or together with a variety of syngo.via-based software options, which are medical devices in their own right.
syngo.via VB10 and the syngo.via VB10 based software options are currently under development, and not for sale in the U.S., China and other countries. Due to regulatory reasons its future availability cannot be guaranteed. Please contact your local Siemens organization for further details.
